Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
19.25
-0.01 (-0.05%)
Apr 29, 2026, 3:04 PM CST

Hualan Biological Vaccine Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2018
Cash & Equivalents
373.56352.94623.04640.98600.04131.56
Upgrade
Short-Term Investments
-458.641,145373.46130-
Upgrade
Trading Asset Securities
2,1901,9731,4581,5991,419825.82
Upgrade
Cash & Short-Term Investments
2,5642,7853,2272,6132,149957.39
Upgrade
Cash Growth
-22.10%-13.69%23.48%21.57%124.50%10.65%
Upgrade
Accounts Receivable
1,1911,3491,4381,9901,7961,439
Upgrade
Other Receivables
0.170.010.411.310.412.15
Upgrade
Receivables
1,1911,3491,4382,4121,8561,441
Upgrade
Inventory
262.62179.2208.84173.47167.16107.41
Upgrade
Other Current Assets
441.969.81103.1328.1820.2223.31
Upgrade
Total Current Assets
4,4594,3834,9775,2274,1932,529
Upgrade
Property, Plant & Equipment
908.86943.711,0711,1761,2871,351
Upgrade
Long-Term Investments
-1,2761,2041,2961,310356.3
Upgrade
Other Intangible Assets
19.8920.0920.8820.1320.7821.43
Upgrade
Long-Term Deferred Tax Assets
185.96189.06212.73217.97208.56182.9
Upgrade
Long-Term Deferred Charges
27.9327.9227.7927.9428.6933.36
Upgrade
Other Long-Term Assets
1,2374.8211.0530.6127.9848.93
Upgrade
Total Assets
6,8396,8447,5237,9957,0764,523
Upgrade
Accounts Payable
71.2560.9881.78116.76125.67185.5
Upgrade
Accrued Expenses
-909.3903.531,1551,050929.48
Upgrade
Short-Term Debt
--300.18300.18300.18500.44
Upgrade
Current Portion of Leases
-----1.03
Upgrade
Current Income Taxes Payable
0.2--50.819.2415.99
Upgrade
Current Unearned Revenue
3.843.68.742.672.681.54
Upgrade
Other Current Liabilities
1,000143.14169.960.6349.1338.19
Upgrade
Total Current Liabilities
1,0761,1171,4641,6861,5371,672
Upgrade
Long-Term Leases
-----0.81
Upgrade
Long-Term Unearned Revenue
21.922.9527.1931.4235.6639.89
Upgrade
Long-Term Deferred Tax Liabilities
--18.815.226.412.5
Upgrade
Total Liabilities
1,0981,1401,5101,7321,5791,715
Upgrade
Common Stock
601.03601.03601.03600.02400.01360
Upgrade
Additional Paid-In Capital
2,9102,9102,9262,9153,089879.79
Upgrade
Retained Earnings
2,3372,3002,5932,7482,0081,568
Upgrade
Treasury Stock
-106.79-106.79-106.79---
Upgrade
Shareholders' Equity
5,7425,7046,0136,2635,4972,808
Upgrade
Total Liabilities & Equity
6,8396,8447,5237,9957,0764,523
Upgrade
Total Debt
--300.18300.18300.18502.27
Upgrade
Net Cash (Debt)
2,5642,7852,9262,3131,849455.12
Upgrade
Net Cash Growth
-14.29%-4.84%26.53%25.07%306.31%-31.59%
Upgrade
Net Cash Per Share
4.314.684.893.843.130.84
Upgrade
Filing Date Shares Outstanding
595595595600.02600.02600.02
Upgrade
Total Common Shares Outstanding
595595595600.02600.02540
Upgrade
Working Capital
3,3833,2663,5123,5412,656857.07
Upgrade
Book Value Per Share
9.659.5910.1110.449.165.20
Upgrade
Tangible Book Value
5,7225,6845,9926,2435,4762,787
Upgrade
Tangible Book Value Per Share
9.629.5510.0710.409.135.16
Upgrade
Buildings
-376.55376.55376.55376.19375.5
Upgrade
Machinery
-1,5031,4961,4721,4501,388
Upgrade
Construction In Progress
-10.276.723.233.26-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.